Characterization of Exposure Versus Response of Edoxaban in Patients Undergoing Total Hip Replacement Surgery Blog Post
Edoxaban is an oral direct factor Xa inhibitor approved for the prevention of venous thromboembolism (VTE) in Japan. The objectives of this analysis were to characterise the population pharmacokinetics (PK)…